tiprankstipranks
Advertisement
Advertisement
Rein Therapeutics Prices $50 Million Public Equity Offering
PremiumCompany AnnouncementsRein Therapeutics Prices $50 Million Public Equity Offering
3M ago
Rein Therapeutics provides update on RENEW clinical trial
Premium
The Fly
Rein Therapeutics provides update on RENEW clinical trial
3M ago
Rein Therapeutics files to sell 30M shares of common stock
Premium
The Fly
Rein Therapeutics files to sell 30M shares of common stock
3M ago
Rein Therapeutics Completes Private Placement of Notes
PremiumCompany AnnouncementsRein Therapeutics Completes Private Placement of Notes
5M ago
Rein Therapeutics Announces Immediate Board Director Resignation
Premium
Company Announcements
Rein Therapeutics Announces Immediate Board Director Resignation
5M ago
Rein Therapeutics downgraded to Hold from Buy at Brookline
Premium
The Fly
Rein Therapeutics downgraded to Hold from Buy at Brookline
6M ago
Rein Therapeutics Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsRein Therapeutics Reports Q3 2025 Financial Results
9M ago
Rein Therapeutics’s LTI-03 Gains Momentum with FDA Clearance and Promising Trial Developments
Premium
Ratings
Rein Therapeutics’s LTI-03 Gains Momentum with FDA Clearance and Promising Trial Developments
9M ago
Rein Therapeutics announces publication on LTI-03
Premium
The Fly
Rein Therapeutics announces publication on LTI-03
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100